Advancing Atopic Dermatitis Remission Criteria with Lebrikizumab Results in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Journal of Allergy and Clinical Immunology 2026

View at publisher

Authors: Bob Geng, Mark Boguniewicz, Vinay Mehta, Luz S. Fonacier, Helena Agell, Zach Dawson, Meihua Qiao, Eric Wolf, Raj Chovatiya

DOI: 10.1016/j.jaci.2025.12.063

Cited by: 0

Fields of Study & Subjects

Dermatology and Skin Diseases Asthma and respiratory diseases Psoriasis: Treatment and Pathogenesis